---
title: "Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from J.P. Morgan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292994536.md"
description: "J.P. Morgan analyst David Adlington maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (0H9X), setting a price target of €37.40. The firm's analyst consensus for the company remains a Moderate Sell, with an average price target consensus of €38.82."
datetime: "2026-07-17T06:25:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292994536.md)
  - [en](https://longbridge.com/en/news/292994536.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292994536.md)
generator: "portal-rs"
---

# Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from J.P. Morgan

In a report released today, David Adlington from J.P. Morgan maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA, with a price target of €37.40.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

According to TipRanks, Adlington is ranked #12047 out of 12329 analysts.

Fresenius Medical Care AG & Co. KGaA has an analyst consensus of Moderate Sell, with a price target consensus of €38.82.

### Related Stocks

- [FME.DE](https://longbridge.com/en/quote/FME.DE.md)
- [FMS.US](https://longbridge.com/en/quote/FMS.US.md)
- [JPM.US](https://longbridge.com/en/quote/JPM.US.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [JPM-M.US](https://longbridge.com/en/quote/JPM-M.US.md)
- [JPM-C.US](https://longbridge.com/en/quote/JPM-C.US.md)
- [JPM-D.US](https://longbridge.com/en/quote/JPM-D.US.md)
- [JPM-L.US](https://longbridge.com/en/quote/JPM-L.US.md)
- [8634.JP](https://longbridge.com/en/quote/8634.JP.md)
- [JPM-K.US](https://longbridge.com/en/quote/JPM-K.US.md)
- [JPM-J.US](https://longbridge.com/en/quote/JPM-J.US.md)

## Related News & Research

- [BlackRock trims Fresenius Medical Care voting rights stake to 6.63% from 7%](https://longbridge.com/en/news/297496680.md)
- [Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from Jefferies](https://longbridge.com/en/news/285171589.md)
- [Canadians Can Now Trade on TipRanks](https://longbridge.com/en/news/297425716.md)
- [TipRanks Analyst Salveen Richter Reiterates Buy on Braveheart Bio, Sets $48 12-Month Target on Strong HCM Opportunity for Lead Asset BHB-1893](https://longbridge.com/en/news/297471640.md)
- [Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Buy from DZ BANK AG](https://longbridge.com/en/news/295174729.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**